The latest data from the Hong Kong Stock Exchange shows that on July 24, JPMorgan Chase & Co. increased its position in Pharmaron (HKEx: 03759) by 213,985 shares.
These shares were purchased at an average price of HKD 23.6887 each, resulting in a total transaction value of approximately HKD 5.069 million.
Following this acquisition, the latest total number of shares held by JPMorgan Chase & Co. stands at approximately 29,000,100 shares, representing an 8.05% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.